| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/04/2004 | CN1473160A Indole derivatives as medicinal compositions for antifungal and/or antiparasitic agents |
| 02/04/2004 | CN1473153A Hetero-anellated ortho-aminophenols |
| 02/04/2004 | CN1473051A Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 02/04/2004 | CN1473043A Method for treating allergies using substituted pyrazoles |
| 02/04/2004 | CN1472209A ²-carboline and sulfo-analogues subsitituted for amino-acid radical, preparing method and application thereof |
| 02/04/2004 | CN1472208A Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
| 02/04/2004 | CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 02/03/2004 | US6686472 Induce the biosynthesis of various cytokines including interferon, and they inhibit tumor formation in animal models |
| 02/03/2004 | US6686470 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 02/03/2004 | US6686374 Azaindoles having serotonin receptor affinity |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686372 Selective β3 adrenergic agonists |
| 02/03/2004 | US6686370 8-(4,4-bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazospiro(4.5) decan-4-one, for example; treating pain with reduced side effects of opioid analgesics; affinity for opioid receptor-like (orl1) receptor |
| 02/03/2004 | US6686369 α-hydrdroxylic acid derivatives, their production and use |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686359 Growth hormone secretagogues |
| 02/03/2004 | US6686358 Anticoagulants; cardoviscular disorders |
| 02/03/2004 | US6686357 Benzimidazolo-piperidine compound |
| 02/03/2004 | US6686356 Pyridoquinoxaline antivirals |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6686349 Administering to a patient for the treatment of sexual dysfunction an effective amount of substituted tetracyclic pyrroloquinolone derivatives |
| 02/03/2004 | US6686318 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 01/29/2004 | WO2004010512A2 Heteroatom-containing diamondoid transistors |
| 01/29/2004 | WO2004009600A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | WO2004009599A1 Five-membered heteroaromatic olefinic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of ncotinic cholinergic receptors |
| 01/29/2004 | WO2004009593A1 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via1h-imidazo [4,5-c]quinolin-4-phthalimide intermediates |
| 01/29/2004 | WO2004009592A1 Bicyclic unsaturated tertiary amine compound |
| 01/29/2004 | WO2004009591A1 A process for the preparation of antipsychotic risperidone |
| 01/29/2004 | WO2004009590A1 4-amino-substituted pyrimidine derivatives |
| 01/29/2004 | WO2004009589A1 Novel 2,5-disubstituted pyrimidine derivatives |
| 01/29/2004 | WO2004009577A1 Heterodiamondoids |
| 01/29/2004 | WO2004009544A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 01/29/2004 | WO2004009118A1 Preventive for the onset of diabetes |
| 01/29/2004 | WO2004009036A2 Compounds compositions and methods |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003053971A8 Pyridoquinoxaline antivirals |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019214 Carbocyclic carbo, oxo amines such as N-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders |
| 01/29/2004 | US20040019213 Nitration of tetrazolo(1,5-a)quinolin-5-ol, then sulfonation, amination, reduction, cyclization, phosphiding and hydrolysis to form 4-amino-1-isobutyl-1H-imidazo(4,5-c)quinoline |
| 01/29/2004 | US20040019099 Treating inflammatory diseases, allergic conditions and central nervous system disorders |
| 01/29/2004 | US20040019076 Nitrogen compounds such as (4-(4- amino-2-butyl-6,7-dimethyl-1H-imidazo(4,5-c)pyridin-1 -yl)butyl)methanesulfonamide, used for induction of cytokines biosynthesis and prophylaxis of viral and tumors; immunology |
| 01/29/2004 | US20040019069 Somatostatin analogue compounds |
| 01/29/2004 | US20040019064 Pyridopyrimidine derivatives as 5-HT6 antagonists |
| 01/29/2004 | US20040019063 Nitrogen compounds such as 4-(7-Hydroxy-1,3-dioxo-tetrahydro-pyrrolo(1,2-c)imidazol-2-yl)-5,6,7,8-tetrahydronaphthalene-1-carbonitrile, used for prophylaxis of muscular disorders; aging |
| 01/29/2004 | US20040019058 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/29/2004 | US20040019056 Anititumoral analogs of et-743 |
| 01/29/2004 | US20040019052 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 01/29/2004 | US20040019049 Substituted quinazolinone compounds |
| 01/29/2004 | US20040019048 Imidazo(4,5-c)quinoline and the 6,7,8,9-tetrahydro derivative having urea, thiourea, acylurea or sulfonylurea at the 1-position as immune response modifiers; biosynthesis of cytokines; viricides; antitumor, -carcinogenic agents |
| 01/29/2004 | US20040019040 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
| 01/29/2004 | US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic |
| 01/29/2004 | US20040019035 3-(5,6,7,8-Tetrahydro-(1,8)naphthyridin-2-yl)-ethoxy)-11H-di-b enzo(1,4)oxazepin-10-yl)-acetic acid; inhibiting bone resorption; vascular restenosis; osteoporosis; angiogenesis inhibitors; diabetic retinopathy; anticarcinogenic agents |
| 01/29/2004 | US20040018986 Viricide against hepatitis virus |
| 01/29/2004 | US20040018192 Integrin expression inhibitors |
| 01/29/2004 | DE10229777A1 Indolin-Phenylsulfonamid-Derivate Indoline derivatives phenylsulfonamide |
| 01/29/2004 | DE10229180A1 Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen Use of vasopeptidase inhibitors for the treatment of metabolic disorders, nephropathy, and diseases associated with AGE |
| 01/29/2004 | CA2493339A1 2-cyano-4-fluoropyrrolidine derivative or salt thereof |
| 01/29/2004 | CA2493227A1 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via1h-imidazo [4,5-c]quinolin-4-phthalimide intermediates |
| 01/29/2004 | CA2492857A1 Heterodiamondoids |
| 01/29/2004 | CA2492726A1 4-amino-substituted pyrimidine derivatives |
| 01/29/2004 | CA2492704A1 Heteroatom-containing diamondoid transistors |
| 01/29/2004 | CA2491251A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/28/2004 | EP1384713A1 4-amino-azepan-3-one derivatives as protease inhibitors |
| 01/28/2004 | EP1384478A1 Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose |
| 01/28/2004 | EP1383771A1 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 01/28/2004 | EP1383769A2 6-substituted pyrazolo 3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| 01/28/2004 | EP1383765A1 Chemical compounds |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
| 01/28/2004 | EP1383733A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | EP1383498A1 Crf receptor antagonists |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | EP1268479B1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
| 01/28/2004 | EP1218382B1 Bicyclic imidazo-3-yl-amine derivatives |
| 01/28/2004 | EP1181335B1 Extended rhodamine compounds useful as fluorescent labels |
| 01/28/2004 | EP0841927B1 Quinolones and their therapeutic use |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471535A Tricyclic derivatives of indole with antiangiogenic activity |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |
| 01/28/2004 | CN1471533A N-([1,2,4] triazoloazinyl) thiophene sulfonamide compounds as herbicides |
| 01/28/2004 | CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471512A Gem-substituted ± ¢ ²3 integrin antagonists |
| 01/28/2004 | CN1471397A Method for treatment of migraine |
| 01/28/2004 | CN1136216C Pyrone carboxy Lic acid derivative or lts salt and antibiotic with the same us effective component |
| 01/28/2004 | CN1136201C Pharmacologucally active enantiomers and method for their preparation |
| 01/28/2004 | CN1136200C Pharmacollogically active enantiomers and method for their preparation |
| 01/28/2004 | CN1136198C Novel benzyl pyrimidines |
| 01/27/2004 | US6683183 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders |
| 01/27/2004 | US6683181 Mixing polystyrene-tosyl chloride resin with c2-12alkynol; reacting with amine to make chemical intermediate; herpes virus treatment |
| 01/27/2004 | US6683142 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 01/27/2004 | US6683124 Fluorescent pigment compositions |
| 01/27/2004 | US6683091 Heterocyclic sulfanamides; alzheimer's disease; preventing deposition of amyloid protein |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683082 3-hetero-arylidene-2-indolinone compounds; anticancer agents |
| 01/27/2004 | US6683075 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
| 01/22/2004 | WO2004007623A1 Oxidation process for preparing quinacridone pigments |